Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.9K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.9K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

496
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
496
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

829
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
829
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

417
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
417
Response Surface Methodology01:16

Response Surface Methodology

889
Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:
889

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A minimally invasive floating-wire interface for transcranial deep brain stimulation.

Brain stimulation·2026
Same author

Synchronization-Dissipation in the Cardiorespiratory System.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Microimager: a flexible thin-film miniaturized endoscope for optical biomedical imaging.

Biomedical optics express·2026
Same author

Reducing scalp pain for pTES of motor cortex using background hums.

Brain stimulation·2026
Same author

Robust minimally-invasive microfabricated stainless steel neural interfaces for high resolution recording.

Nature communications·2026
Same author

Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis.

Annals of surgical oncology·2025

Related Experiment Video

Updated: Apr 26, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.4K

Formulation optimization of erythromycin solid lipid nanocarrier using response surface methodology.

Anil Kumar Sahu1, Tekeshwar Kumar1, Vishal Jain1

  • 1University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur 492010, India.

Biomed Research International
|July 22, 2014
PubMed
Summary
This summary is machine-generated.

Optimized erythromycin solid lipid nanocarriers (ERY-SLN) using response surface methodology (RSM). The best formulation achieved high drug entrapment and loading, with a small particle size and sustained release over 24 hours.

More Related Videos

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.3K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

24.6K

Related Experiment Videos

Last Updated: Apr 26, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.4K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.3K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

24.6K

Area of Science:

  • Pharmaceutical Sciences
  • Nanotechnology
  • Drug Delivery

Background:

  • Erythromycin requires effective delivery systems to improve therapeutic outcomes.
  • Solid lipid nanocarriers (SLN) offer a promising platform for drug delivery due to their biocompatibility and controlled release properties.

Purpose of the Study:

  • To optimize the formulation of erythromycin-loaded solid lipid nanocarriers (ERY-SLN) using response surface methodology (RSM).
  • To characterize the optimized ERY-SLN for entrapment efficiency, drug loading, particle size, and stability.

Main Methods:

  • Response surface methodology (RSM) with a two-factor, three-level factorial design was employed.
  • Independent variables included lipid concentration and surfactant:cosurfactant ratio.
  • Key parameters optimized were drug entrapment efficiency (EE), drug loading (DL), and mean particle size.

Main Results:

  • The optimal ERY-SLN formulation used 15 mg/mL lipid concentration and a 1:1 surfactant:cosurfactant ratio.
  • %EE was 88.40 ± 2.09%, DL was 29.46 ± 0.69%, and mean particle size was 153.21 ± 2.31 nm.
  • Differential scanning calorimetry (DSC) and transmission electron microscopy (TEM) confirmed drug-lipid compatibility and nonspherical particle morphology. Sustained release up to 66.26% over 24h was observed.

Conclusions:

  • Optimized ERY-SLN formulations demonstrate favorable characteristics for drug delivery.
  • The developed nanocarriers exhibit good stability and sustained drug release profiles.
  • RSM is an effective tool for optimizing ERY-SLN formulations.